Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis.
Citations
31 citations
31 citations
Cites background from "Pharmacotherapy for neuropathic pai..."
...First-line drugs for neuropathic pain include antidepressants and anticonvulsants acting at calcium channels [75]....
[...]
...Second- and Third-Line Drugs for neuropathic pain include topical analgesics, opioids, and corticosteroids [75]....
[...]
31 citations
Cites background from "Pharmacotherapy for neuropathic pai..."
...linum neurotoxin/A has also shown effectiveness in the treatment for chronic migraine after injections in the scalp muscles.(14,25) There is, however, considerable confusion over the mechanism of BoNT/A-mediated antinociception....
[...]
...A recent metaanalysis of the clinical literature has also recommended local BoNT/A treatment for peripheral neuropathic pain and only at subparalytic doses.(14)...
[...]
31 citations
Cites result from "Pharmacotherapy for neuropathic pai..."
...Our results are therefore promising and show a potential role for iv lidocaine in patients with CIPN, when standard treatment algorithm for neuropathic pain fails [40]....
[...]
31 citations
Cites background or result from "Pharmacotherapy for neuropathic pai..."
...Moreover, these results agree with evidence for the clinical effectiveness of morphine and other opioids to treat neuropathic pain (Finnerup et al., 2015) and with evidence for sustained analgesic effects of mu opioids during chronic opioid treatment in many clinical contexts (Foley, 1995; Rosenblum et al....
[...]
...For example, current treatments are considered to be largely symptomatic, and one recent metaanalysis found that currently available pharmacotherapies are effective in only a fraction of the patients treated (Finnerup et al., 2015)....
[...]
...For example, one recent meta-analysis of treatments for neuropathic pain recommended against use of THC (Finnerup et al., 2015)....
[...]
...…have also shown relatively good effectiveness to treat neuropathic pain, although the compounds usually used to treat neuropathic pain (e.g. amitryptiline) are more selective to block transporters of norepinephrine and/or serotonin than dopamine (Watson et al., 2006; Finnerup et al., 2015)....
[...]
...Moreover, these results agree with evidence for the clinical effectiveness of morphine and other opioids to treat neuropathic pain (Finnerup et al., 2015) and with evidence for sustained analgesic effects of mu opioids during chronic opioid treatment in many clinical contexts (Foley, 1995;…...
[...]
References
62,157 citations
46,935 citations
37,989 citations
15,740 citations
13,324 citations